scispace - formally typeset
D

Dominique P.V. de Kleijn

Researcher at University Medical Center Utrecht

Publications -  84
Citations -  10315

Dominique P.V. de Kleijn is an academic researcher from University Medical Center Utrecht. The author has contributed to research in topics: Medicine & Myocardial infarction. The author has an hindex of 26, co-authored 63 publications receiving 8726 citations. Previous affiliations of Dominique P.V. de Kleijn include Utrecht University & National University of Singapore.

Papers
More filters
Journal ArticleDOI

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.

TL;DR: The novel role of exosomes highlights a new perspective into intercellular mediation of tissue injury and repair, and engenders novel approaches to the development of biologics for tissue repair.
Journal ArticleDOI

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

Thomas Lener, +57 more
TL;DR: In this paper, the authors summarize recent developments and the current knowledge of extracellular vesicles (EVs) and discuss safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application.
Journal ArticleDOI

Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury

TL;DR: This study shows that intact exosomes restore bioenergetics, reduce oxidative stress and activate pro-survival signaling, thereby enhancing cardiac function and geometry after myocardial I/R injury, and Hence, mesenchymal stem cell-derived exosome are a potential adjuvant to reperfusion therapy for my cardiac infarction.
Journal ArticleDOI

Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium.

TL;DR: The data identify human MSC-CM as a promising therapeutic option to reduce myocardial infarct size in patients with acute MI and suggest that the use of stem cell secretions could extend the applicability of stem cells for therapeutic purposes.
Journal ArticleDOI

Frameshift Mutants of β Amyloid Precursor Protein and Ubiquitin-B in Alzheimer's and Down Patients

TL;DR: The cerebral cortex of Alzheimer's and Down syndrome patients is characterized by the presence of protein deposits in neurofibrillary tangles, neuritic plaques, and neuropil threads.